|
| 34373643 | Remote smartphone monitoring of Parkinson's disease and individual response to therapy. | Nat Biotechnol | 2022 |
| 35925980 | Disentangling personalized treatment effects from "time-of-the-day" confounding in mobile health studies. | PLoS One | 2022 |
| 33275082 | Assessment of the <i>All of Us</i> research program's informed consent process. | AJOB Empir Bioeth | 2021 |
| 30975992 | Physical activity, sleep and cardiovascular health data for 50,000 individuals from the MyHeart Counts Study. | Sci Data | 2019 |
| 31633058 | Detecting the impact of subject characteristics on machine learning-based diagnostic applications. | NPJ Digit Med | 2019 |
| 31304325 | The Healthy Pregnancy Research Program: transforming pregnancy research through a ResearchKit app. | NPJ Digit Med | 2018 |
| 29786695 | The asthma mobile health study, smartphone data collected using ResearchKit. | Sci Data | 2018 |
| 27864015 | Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. | Lancet Oncol | 2017 |
| 28453697 | Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. | Ann Oncol | 2017 |
| 28195576 | The Mole Mapper Study, mobile phone skin imaging and melanoma risk data collected using ResearchKit. | Sci Data | 2017 |
| 27993815 | Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes. | Ann Oncol | 2017 |
| 28209557 | Formative Evaluation of Participant Experience With Mobile eConsent in the App-Mediated Parkinson mPower Study: A Mixed Methods Study. | JMIR Mhealth Uhealth | 2017 |
| 26708336 | rCGH: a comprehensive array-based genomic profile platform for precision medicine. | Bioinformatics | 2016 |
| 26977904 | A large dataset of protein dynamics in the mammalian heart proteome. | Sci Data | 2016 |
| 27384501 | Mobile health: the power of wearables, sensors, and apps to transform clinical trials. | Annals of the New York Academy of Sciences | 2016 |
| 26776193 | PERSONALIZED HYPOTHESIS TESTS FOR DETECTING MEDICATION RESPONSE IN PARKINSON DISEASE PATIENTS USING iPHONE SENSOR DATA. | Pac Symp Biocomput | 2016 |
| 26938265 | The mPower study, Parkinson disease mobile data collected using ResearchKit. | Sci Data | 2016 |
| 26020786 | Summary of the DREAM8 Parameter Estimation Challenge: Toward Parameter Identification for Whole-Cell Models. | PLoS Comput Biol | 2015 |
| 25656898 | Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors. | Cancer Discov | 2015 |
| 25305506 | Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. | Gastroenterology | 2015 |
| 26457759 | The consensus molecular subtypes of colorectal cancer. | Nat Med | 2015 |
| 24479813 | ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma. | BMC Urol | 2014 |
| 24374825 | Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma. | Carcinogenesis | 2014 |
| 24240109 | Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials. | Clinical Cancer Research | 2014 |
| 23707516 | A phase II flexible screening design allowing for interim analysis and comparison with historical control. | Contemp Clin Trials | 2013 |
| 24303291 | clearScience: Infrastructure for Communicating Data-Intensive Science. | AMIA Jt Summits Transl Sci Proc | 2013 |
| 23980089 | Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database. | J Clin Oncol | 2013 |
| 23780890 | Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology. | Clin Cancer Res | 2013 |
| 23658707 | Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination. | PLoS One | 2013 |
| 22047647 | Expression of endothelin 2 and localized clear cell renal cell carcinoma. | Human Pathology | 2012 |
| 22281773 | Developing predictive molecular maps of human disease through community-based modeling. | Nat Genet | 2012 |
| 22769017 | Technical and biological variance structure in mRNA-Seq data: life in the real world. | BMC Genomics | 2012 |
| 21646604 | Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials. | J Clin Oncol | 2011 |
| 21257306 | Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803. | Eur J Cancer | 2011 |
| 21364760 | Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing. | PLoS One | 2011 |
| 21533822 | Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis. | Ann Surg Oncol | 2011 |
| 20479400 | Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation. | Journal of Clinical Oncology | 2010 |
| 20008641 | Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set. | J Clin Oncol | 2010 |
| 19712457 | Evaluation of a new high-dimensional miRNA profiling platform. | BMC Med Genomics | 2009 |
| 19255311 | Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer. | Journal of Clinical Oncology | 2009 |
| 17336213 | Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer. | International Journal of Radiation Oncology Biology Physics | 2007 |
| 17409917 | Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trials. | Journal of Thoracic Oncology | 2006 |